オルメサルタンの脳グルコース代謝、血管炎症および脂肪組織に対する有効性

基本情報

NCT ID: NCT02996916
ステータス: 不明
試験のフェーズ: 第4相
試験タイプ: 介入
目標被験者数: 100
治験依頼者名: Kurume University

概要

Hypertension is a leading risk factor for morbidity and mortality worldwide. The brain is a major target of the damaging effects of hypertension. Hypertension has been recognized as the leading cause of dementia as well as the most important risk factor for stroke and vascular cognitive impairment. Although glucose is the principal cerebral energy source, impact of hypertensive treatment on cerebral glucose metabolism is poorly understood.

対象疾患

Efficacy of Olmesartan on Cerebral Glucose Metabolism in Essential Hypertension

介入

Olmesartan(DRUG)

Amlodipine(DRUG)

依頼者（Sponsor）

Kurume University(OTHER)

実施施設 (1)

久留米大学病院

Kurume, Japan(RECRUITING)